Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

 

MyMD Pharmaceuticals, Inc.

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security Type 

Security

Class

Title

  Fee Calculation or Carry Forward Rule  Amount Registered (1)   Proposed Maximum Offering Price Per Unit   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee   Carry Forward Form Type   Carry Forward File Number   Carry Forward Initial effective date   Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward 
Newly Registered Securities
Fees to Be
Paid		  Equity  Common Stock, par value $0.001 per share  Rule 457(c)   473,841(2)  $2.145(3)  $1,016,388.95   $0.00014760   $150.02                               
Fees
Previously
Paid		                                                      
Carry Forward Securities
Carry
Forward
Securities		                                                      
   Total Offering Amounts        $1,016,388.95                               
   Total Fees Previously Paid                                         
   Total Fee Offsets                                         
   Net Fee Due                  $150.02                     

 

(1) Pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock, par value $0.001 per share (the “Common Stock”), as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
   
(2) Represents an aggregate of 473,841 shares of Common Stock issuable upon the conversion of shares of Series F-1 convertible preferred stock, upon the conversion of shares of Series G convertible preferred stock, or upon exercise of certain warrants.
   
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on June 18, 2024, which such date is within five business days of the filing of this registration statement, of $2.145 per share.